Table 3. Changes of monthly age-standardized hospitalization rates associated with Dengue, Zika and Chikungunya incidence in the 27 Brazilian States.
| DENV incidence | ZIKV incidence | CHIKV incidence | |
|---|---|---|---|
| RR (95% CrI) | RR (95% CrI) | RR (95% CrI) | |
| All causes | 1.0001 (1–1.0002) | 1 (0.9987–1.0015) | 1.0003 (0.9998–1.0009) |
| By chapter | |||
| Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) | 1.0001 (1–1.0002) | 1.0003 (0.9988–1.0019) | 1.0004 (0.9998–1.0011) |
| Endocrine, nutritional and metabolic diseases (E00-E89) | 1 (0.9999–1.0002) | 1.0011 (0.9997–1.0026) | 1.0001 (0.9995–1.0007) |
| Diseases of the circulatory system (I00-I99) | 1 (0.9999–1.0002) | 0.9999 (0.9985–1.0014) | 1.0003 (0.9998–1.0009) |
| Mental and behavioural disorders (F01-F99) | 1.0001 (0.9999–1.0003) | 1.0007 (0.9987–1.0028) | 1.0005 (0.9996–1.0014) |
| Diseases of the nervous system (G00-G99) | 1 (0.9999–1.0002) | 0.9993 (0.9977–1.0009) | 1 (0.9994–1.0007) |
| Diseases of the eye and adnexa (H00-H59) | 1.0001 (0.9998–1.0004) | 1.0005 (0.9978–1.0034) | 1.0005 (0.999–1.002) |
| Diseases of the respiratory system (J00-J99) | 1.0002 (1–1.0004) | 1.0007 (0.999–1.0025) | 1.0005 (0.9999–1.0012) |
| Diseases of the digestive system (K00-K95) | 1 (0.9999–1.0002) | 1.0001 (0.9987–1.0016) | 1.0003 (0.9997–1.0009) |
| Diseases of the skin and subcutaneous tissue (L00-L99) | 1 (0.9998–1.0001) | 1.0009 (0.9993–1.0025) | 1.0008 (1.0001–1.0014) |
| Diseases of the musculoskeletal system and connective tissue (M00-M99) | 1.0001 (0.9999–1.0002) | 1.0001 (0.9984–1.0019) | 1.0001 (0.9994–1.0008) |
| Diseases of the genitourinary system (N00-N99) | 1 (0.9999–1.0002) | 1 (0.9985–1.0014) | 1.0003 (0.9997–1.0009) |
| By causes | |||
| Diabetes mellitus (E10-E13) | 1 (0.9999–1.0002) | 1.0014 (0.9997–1.0031) | 1.0007 (1–1.0014) |
| Cerebrovascular diseases (I60-I69) | 1 (0.9999–1.0002) | 1.0001 (0.9986–1.0018) | 1.0005 (0.9999–1.0012) |
| Hypertensive diseases (I10-I15) | 1 (0.9999–1.0002) | 0.9993 (0.9976–1.001) | 1.0001 (0.9994–1.0008) |
| Ischemic heart diseases (I20-I25) | 1 (0.9998–1.0001) | 0.9991 (0.9976–1.0007) | 0.9999 (0.9993–1.0005) |
| Inflammatory diseases of the central nervous system (G00-G09) | 1.0001 (0.9999–1.0004) | 0.9991 (0.9962–1.0021) | 0.9998 (0.9987–1.0009) |
| Encephalitis, myelitis and encephalomyelitis; Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere (G04-G05) | 0.9999 (0.9995–1.0004) | 0.9995 (0.9921–1.0068) | 0.9991 (0.9976–1.0007) |
| Sequelae of inflammatory diseases of central nervous system (G09) | 1 (0.9994–1.0006) | 1.0027 (0.9935–1.0125) | 0.9961 (0.9892–1.0033) |
| Acute myocarditis (I40) | 0.9998 (0.9992–1.0003) | 1.002 (0.9956–1.0078) | 1 (0.9963–1.0032) |
| Arthropathies (M00-M25) | 0.9999 (0.9997–1.0001) | 0.9999 (0.998–1.0019) | 0.9996 (0.9988–1.0004) |
| Inflammatory polyneuropathy (including Guillain-Barré) (G61) | 1.0004 (1.0001–1.0007) | 1.0054 (1.0025–1.0084) | 1.0006 (0.9993–1.002) |
| Pregnancy with abortive outcome (O00-O08) | 0.9999 (0.9998–1) | 0.9997 (0.9982–1.0012) | 0.9996 (0.999–1.0002) |
*Model presented poor fit